# Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax)

> **NCT03460730** · PHASE1 · COMPLETED · sponsor: **KEMRI-Wellcome Trust Collaborative Research Program** · enrollment: 100 (actual)

## Conditions studied

- Pneumonia, Pneumococcal

## Interventions

- **BIOLOGICAL:** Pneumovax

## Key facts

- **NCT ID:** NCT03460730
- **Lead sponsor:** KEMRI-Wellcome Trust Collaborative Research Program
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11-04
- **Primary completion:** 2006-07-03
- **Final completion:** 2006-07-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2018-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03460730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03460730, "Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03460730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*